Strax

Autospela

Dr. Moskowitz on the ALCANZA Trial in CTCL

5 Visningar • 08/09/23
Dela med sig
Bädda in
administrator
administrator
Prenumeranter
0

Alison J. Moskowitz, MD, clinical director, Lymphoma Inpatient Unit, Memorial Sloan Kettering Cancer Center, discusses the data that led to the approval of brentuximab vedotin (Adcetris) in patients with cutaneous T-cell lymphoma (CTCL).

Visa mer
0 Kommentarer sort Sortera efter
Facebook-kommentarer

Strax

Autospela